As of 2025-10-30, the EV/EBITDA ratio of Ramm Pharma Corp (RAMM.CN) is -0.28. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RAMM.CN's latest enterprise value is 1.29 mil CAD. RAMM.CN's TTM EBITDA according to its financial statements is -4.68 mil CAD. Dividing these 2 quantities gives us the above RAMM.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 2.4x - 5.7x | 3.4x |
| Forward P/E multiples | 0.8x - 1.6x | 0.9x |
| Fair Price | (0.12) - (0.08) | (0.11) |
| Upside | -698.8% - -495.1% | -633.5% |
| Date | EV/EBITDA |
| 2025-10-24 | -0.08 |
| 2025-10-07 | -0.18 |
| 2025-09-26 | -0.08 |
| 2025-09-23 | -0.18 |
| 2025-09-19 | -0.18 |
| 2025-09-18 | -0.08 |
| 2025-09-17 | -0.08 |
| 2025-09-12 | -0.08 |
| 2025-09-04 | -0.08 |
| 2025-09-03 | -0.18 |
| 2025-09-02 | -0.18 |
| 2025-08-01 | -0.08 |